TRVI
Trevi Therapeutics, Inc. · Healthcare
10% owner David M Mott bought $25.0M of Trevi Therapeutics, Inc.
Bought$25,000,000
$10.00Price
2,500,000Shares
+129%Stake
What TRVI did for a copier
Prices for TRVI after this filing aren't in yet.
David M Mott's record
9 other buys with 3 months of prices since 2016: on average +19.6% against the S&P 500, and 7 of 9 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 9. Filed Mon, May 13, 1:14 PM ET, during the session. Not investment advice.